Related Experiment Video

Updated: Jul 5, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways

Aymen I Idris1, Aymen Idris, Emanuela Mrak

  • 1Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh, EH4 2XU, UK.

Biochemical and Biophysical Research Communications
|April 17, 2008
PubMed

Insights

The compound ABD56 inhibits osteoclast formation and induces apoptosis by blocking key survival pathways, not by activating stress pathways. This offers a potential therapeutic target for bone diseases.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Pharmacology

Background:

  • Osteoclasts are crucial for bone remodeling.
  • Dysregulated osteoclast activity contributes to bone diseases.
  • The biphenylcarboxylic acid butanediol ester (ABD56) is known to inhibit osteoclast formation and activity.

Purpose of the Study:

  • To elucidate the mechanism of action of ABD56 on osteoclasts.
  • To investigate the effects of ABD56 on osteoclast-related signaling pathways.
  • To determine whether ABD56 induces apoptosis via stress-activated pathways or inhibition of survival pathways.

Main Methods:

  • Osteoclast differentiation and apoptosis assays.
  • Western blotting to assess protein phosphorylation (p38, JNK, ERK1/2, IkappaB).
  • Nuclear translocation assays for c-jun.
  • Inhibition studies using specific pathway inhibitors and varying RANKL concentrations.

Main Results:

  • ABD56 inhibited osteoclast formation and induced apoptosis without affecting osteoblasts or macrophages.
  • ABD56 treatment led to phosphorylation of p38 and JNK, and nuclear translocation of c-jun.
  • Apoptosis induced by ABD56 was caspase-dependent but not rescued by p38 or JNK inhibitors.
  • ABD56 abolished RANKL-induced phosphorylation of IkappaB and ERK1/2.
  • Partial rescue of ABD56-induced apoptosis by increased RANKL suggests inhibition of survival signals.

Conclusions:

  • ABD56 induces osteoclast apoptosis primarily by inhibiting essential survival pathways, including NF-kappaB and ERK.
  • The compound's mechanism involves blocking RANKL signaling, leading to the disruption of osteoclast survival.
  • ABD56 represents a potential therapeutic agent for conditions characterized by excessive osteoclast activity.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...